P41Women's health study of Mycoplasma genitalium: a feasibility study

BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.MethodsWomen aged 16-24years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.ResultsRecruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p